BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND STAT3, FLJ20882, 6774, ENSG00000168610, APRF, P40763, MGC16063 AND Treatment
555 results:

  • 1. KIAA0040 enhances glioma growth by controlling the JAK2/stat3 signalling pathway.
    He J; Xue K; Fan F; Li L; Rao X; Liu W; Nie C
    J Cell Mol Med; 2024 Apr; 28(8):e18332. PubMed ID: 38661644
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Expression of stat3 and hypoxia markers in long-term surviving malignant glioma patients.
    Dvorakova K; Skarkova V; Vitovcova B; Soukup J; Vosmikova H; Pleskacova Z; Skarka A; Bartos MC; Krupa P; Kasparova P; Petera J; Rudolf E
    BMC Cancer; 2024 Apr; 24(1):509. PubMed ID: 38654280
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Nuclear autoantigenic sperm protein facilitates glioblastoma progression and radioresistance by regulating the ANXA2/stat3 axis.
    Qiu Y; Pei D; Wang M; Wang Q; Duan W; Wang L; Liu K; Guo Y; Luo L; Guo Z; Guan F; Wang Z; Xing A; Liu Z; Ma Z; Jiang G; Yan D; Liu X; Zhang Z; Wang W
    CNS Neurosci Ther; 2024 Apr; 30(4):e14709. PubMed ID: 38605477
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. EPIC-0628 abrogates HOTAIR/EZH2 interaction and enhances the temozolomide efficacy via promoting ATF3 expression and inhibiting DNA damage repair in glioblastoma.
    Yang E; Hong B; Wang Y; Wang Q; Zhao J; Cui X; Wu Y; Yang S; Su D; Liu X; Kang C
    Cancer Lett; 2024 Apr; 588():216812. PubMed ID: 38490327
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Inhibition of PRMT1 Suppresses the Growth of U87MG-Derived Glioblastoma Stem cells by Blocking the stat3 Signaling Pathway.
    Yuk N; Jung HJ
    Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474197
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Zeaxanthin impairs angiogenesis and tumor growth of glioblastoma: An in vitro and in vivo study.
    Lu F; Wu Q; Lei J; Zhou Y; Liu Y; Zhu N; Yu Y; Lin L; Hu M
    Arch Biochem Biophys; 2024 Apr; 754():109957. PubMed ID: 38467357
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Antiproliferative effect of Potentilla fulgens on glioblastoma cancer cells through downregulation of Akt/mTOR signaling pathway.
    Kandemir SI; Ipek P
    J Cancer Res Ther; 2023 Oct; 19(7):1818-1824. PubMed ID: 38376284
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Exposure of human glioblastoma cells to thimerosal inhibits the thioredoxin system and decreases tumor growth-related factors.
    Bramatti I; Aschner M; Branco V; Carvalho C
    Toxicol Appl Pharmacol; 2024 Mar; 484():116844. PubMed ID: 38325586
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Investigating the therapeutic effects of novel compounds targeting inflammatory IL-1β and IL-6 signaling pathways in spinocerebellar ataxia type 3.
    Chen IC; Chen WL; Chang KH; Lee JW; Lin TH; Lin W; Chen CM; Lee-Chen GJ
    Eur J Pharmacol; 2024 Mar; 967():176370. PubMed ID: 38320719
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Spatial profiling reveals tissue-specific neuro-immune interactions in gastroenteropancreatic neuroendocrine tumors.
    Duan S; Sawyer TW; Witten BL; Song H; Else T; Merchant JL
    J Pathol; 2024 Mar; 262(3):362-376. PubMed ID: 38229586
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. The predictive efficacy of programmed cell death in immunotherapy of melanoma: A comprehensive analysis of gene expression data for programmed cell death biomarker and therapeutic target discovery.
    Yue C; Lian W; Duan M; Xia D; Cao X; Peng J
    Environ Toxicol; 2024 Mar; 39(3):1858-1873. PubMed ID: 38140739
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. REC8 regulates neuroblastoma cell proliferation, migration, invasion, and angiogenesis via stat3/VEGF signaling.
    Wang Q; Fan W; Hao Z; Liang B; Fan M; Zhao Z; Li Z
    J Egypt Natl Canc Inst; 2023 Dec; 35(1):41. PubMed ID: 38105365
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Synergistic effect of cryptotanshinone and temozolomide treatment against human glioblastoma cells.
    Zhu S; Guo J; Yu L; Liu J; Chen J; Xin J; Zhang Y; Luo J; Duan C
    Sci Rep; 2023 Dec; 13(1):21835. PubMed ID: 38071213
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Prevention of stat3-related pathway in SK-N-SH cells by natural product astaxanthin.
    Sun SQ; Du FX; Zhang LH; Hao-Shi ; Gu FY; Deng YL; Ji YZ
    BMC Complement Med Ther; 2023 Nov; 23(1):430. PubMed ID: 38031104
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. RPL22L1, a novel candidate oncogene promotes temozolomide resistance by activating stat3 in glioblastoma.
    Chen Y; Mu Y; Guan Q; Li C; Zhang Y; Xu Y; Zhou C; Guo Y; Ma Y; Zhao M; Ji G; Liu P; Sun D; Sun H; Wu N; Jin Y
    Cell Death Dis; 2023 Nov; 14(11):757. PubMed ID: 37985768
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Xihuang pill facilitates glioma cell pyroptosis via the POU4F1/stat3 axis.
    Tang N; Zhu Y; Yu J
    Funct Integr Genomics; 2023 Nov; 23(4):334. PubMed ID: 37962640
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. JAK3 Inhibition Regulates Stemness and Thereby Controls Glioblastoma Pathogenesis.
    Smedley W; Patra A
    Cells; 2023 Oct; 12(21):. PubMed ID: 37947625
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. KIF22 promotes the proliferation and glycolysis of melanoma by activating EGFR/stat3 signaling.
    Zhong Z; Zhong H
    Clinics (Sao Paulo); 2023; 78():100307. PubMed ID: 37944197
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Combining organotypic tissue culture with light-sheet microscopy (OTCxLSFM) to study glioma invasion.
    Haydo A; Wehle A; Herold-Mende C; Kögel D; Pampaloni F; Linder B
    EMBO Rep; 2023 Dec; 24(12):e56964. PubMed ID: 37938214
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Synthesis and characterization of piperic acid conjugates with homochiral and heterochiral dipeptides containing phenylalanine and their application in skin cancer.
    Ur Rahim J; Faheem MM; Nawaz S; Goswami A; Rai R
    Peptides; 2023 Dec; 170():171113. PubMed ID: 37923167
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 28.